This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Impact of tDCS on Cerebral Autoregulation

This study has been completed.
Information provided by (Responsible Party):
Agnes Flöel, Charite University, Berlin, Germany Identifier:
First received: December 18, 2012
Last updated: March 15, 2016
Last verified: March 2016
The aim of the study is to investigate whether there is a polarity-specific influence of tDCS on cerebral vasomotor reactivity monitored by transcranial doppler sonography.

Condition Intervention
Cerebral Microangiopathy CADASIL Migraine With Aura ICA Stenosis Device: Anodal tDCS Device: Cathodal tDCS Device: sham tDCS

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science

Resource links provided by NLM:

Further study details as provided by Agnes Flöel, Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Cerebral vasomotor reactivity assessed by transcranial Dopplersonography [ Time Frame: on 3 days within 12 weeks ]
    comparing cerebral vasomotor reactivity at baseline and after anodal/cathodal/sham stimulation

Enrollment: 60
Study Start Date: April 2012
Study Completion Date: March 2014
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Anodal tDCS
anaodal transcranial direct current stimulation
Device: Anodal tDCS
Active Comparator: Cathodal tDCS
cathodal transcranial direct current stimulation
Device: Cathodal tDCS
Sham Comparator: Sham tDCS
no stimulation
Device: sham tDCS


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  1. severe cerebral Microangiopathy
  2. NOTCH3 carrier
  3. Migraine with aura (IHS Classification ICHD-II)
  4. Stenosis >80%, ECST-Criteria

Exclusion Criteria:

  • seizure disorder
  • history of severe alcohol or drug abuse, psychiatric illness like severe depression, poor motivational capacity
  • dementia

(1+2) history of stroke in past 3 months (3) migraine prophylaxis (4) contralateral stenosis >50%,

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01865604

Department of Neurology, Charité Universitätsmedizin Berlin
Berlin, Germany, 10117
Sponsors and Collaborators
Charite University, Berlin, Germany
Principal Investigator: Agnes Flöel, Prof. MD Charite University, Berlin, Germany
  More Information

Responsible Party: Agnes Flöel, Prof. Dr. med. Agnes Floeel, Charite University, Berlin, Germany Identifier: NCT01865604     History of Changes
Other Study ID Numbers: tDCS_cVMR
Study First Received: December 18, 2012
Last Updated: March 15, 2016

Additional relevant MeSH terms:
Migraine with Aura
Cerebral Small Vessel Diseases
Migraine Disorders
Headache Disorders, Primary
Headache Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Cerebrovascular Disorders
Dementia, Vascular
Cerebral Arterial Diseases
Intracranial Arterial Diseases
Vascular Diseases
Cardiovascular Diseases
Genetic Diseases, Inborn processed this record on September 21, 2017